Key result
Hepatogenous diabetes, affecting 30% to 60% of cirrhotic patients, serves as a marker for liver function deterioration and is associated with increased mortality and cirrhosis complications.
Hepatogenous diabetes is a distinct metabolic disorder in cirrhotic patients that serves as a marker for liver function deterioration and complicates treatment.
No takes yet. Share an insight, caveat, or question.
May inform prognostic stratification in cirrhosis; leaves open whether targeted intervention improves outcomes.
García‐Compeán et al. (2009) conducted a review in Hepatogenous diabetes in cirrhosis. Hepatogenous diabetes was evaluated. Hepatogenous diabetes, affecting 30% to 60% of cirrhotic patients, serves as a marker for liver function deterioration and is associated with increased mortality and cirrhosis complications.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: